NEURAXIS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEURAXIS, INC. stock issued during period, value, other for the quarter ending 2026-06-30 was $2.07M, a 58.59% decline year-over-year.
- NEURAXIS, INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $2.99M.
- NEURAXIS, INC. stock issued during period, value, other for the quarter ending 2025-06-30 was $5.00M.
- NEURAXIS, INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $4.94M.
- NEURAXIS, INC. stock issued during period, value, other for fiscal 2025 was $7.73M, a 56.60% increase from fiscal 2024.
- NEURAXIS, INC. stock issued during period, value, other for fiscal 2024 was $4.94M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $2.99M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $7.73M 10-K · filed 2026-03-19 | |
| 2025-06-30 | $5.00M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $4.94M 10-K · filed 2025-03-20 | |
| 2024-09-30 | $4.94M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |